GlassScriptPhysician profile
William C Huang
NPI 1235274101
$55,229.56
in general payments reported to CMS, 2019-2025
17 companies · $26K in 2025
The $26K reported for 2025 was more than what 97% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,731 · 2020: $26.34 · 2021: $5,350 · 2022: $4,361 · 2023: $8,467 · 2024: $6,580 · 2025: $26K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $17K · Travel and Lodging: $11K · Consulting Fee: $7,942 · Food and Beverage: $4,206 · Education: $940.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $16,800.00 |
| Travel and Lodging | $10,873.82 |
| Consulting Fee | $7,941.50 |
| Food and Beverage | $4,205.69 |
| Education | $940.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $33,683.44 | 2021-2025 | Jelmyto |
| Histosonics, INC. | $7,117.04 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $3,788.18 | 2024-2025 | Adstiladrin |
| Intuitive Surgical, INC. | $3,512.46 | 2019-2025 | Da Vinci Surgical System |
| Merck Sharp & Dohme LLC | $2,604.04 | 2019-2021 | |
| Janssen Scientific Affairs, LLC | $1,690.02 | 2025 | |
| Telix Pharmaceuticals | $1,278.87 | 2023 | Illuccix |
| Pfizer INC. | $836.45 | 2019-2024 | |
| Abbvie INC. | $236.14 | 2023-2024 | |
| Procept Biorobotics Corporation | $178.43 | 2025 | |
| Medtronic Vascular, INC. | $141.59 | 2019 | |
| Biotissue Holdings INC. | $95.00 | 2019 | |
| Astellas Pharma US INC | $24.33 | 2024 | Xtandi |
| Medtronic, INC. | $22.83 | 2023 | Endo Clip III |
| Boston Scientific Corporation | $20.74 | 2024 | Spaceoar Vue System - 10ml |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Huang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.